Significance of prostate specific antigen in prostate cancer patients and in non cancerous prostatic disease patients

Journal of the Pakistan Medical Association

Volumn 57, Issue 5, 2007, Pages 248-251

  Hanif, Muhammad ^a   Zaidi, Parveen ^a   Kamal, Shahid ^a   Idrees, Samreen ^b   Rasool, Sheikh Ajaz ^c  

^a Karachi Institute of Radiotherapy & Nuclear Medicine   (Pakistan)

^b JINNAH UNIVERSITY FOR WOMEN   (Pakistan)

^c UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; RADIOIMMUNOASSAY; TUMOR BIOPSY; BLOOD; COMPARATIVE STUDY; EVALUATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOIMMUNOASSAY; RADIONUCLIDE IMAGING;

EID: 34548858757     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hsing AW, Tsao L, Devasa SS. International trend and patterns of prostate cancer incidence and mortality. Int J Cancer 2000;85:60-7.
2. Boring C, Squires TS, Tong T, Montgomery S. Cancer statistics, CA Cancer J Clin1994;44:7-26.
3. Aziz Z, Sana S, Saeed S, Akram M. Institution based tumor registry from Punjab: Five year data based analysis. J Med Pak Assoc 2003;53:350-3.
4. Gittea RF. Prostate-specific antigen. N Engl J Med 1987;317:954-5.
5. Wang MC, Chu TM, Kuciel R, Valenzuela L, Murphy GP. Enzyme markers in human prostatic carcinoma. Cancer Treat Rep 1977;61:193-209.
6. Schifman RB, Ahmann FR, Elvick A, Ahmann M, Coulis K, Brawer MK. Analytical and physiological characteristics of prostate- specific antigen and prostatic acid phosphatase in serum compared. Clin Chem 1987;33:2086-8.
7. Kuriyama M, Wang MC, Papridero LD, Killian CS, Schimone T, Valenzuela L, et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980;40:4658-62.
8. Kuriyama M, Wang MC, Papsidero LD, Killian CS, Schimono T, Valenzuela L, et al. Prostate antigen of human cancer patients. Methods Cancer Rea 1982;19:179-97.
9. Loor R, M'Timkulu T, Dewitt SK. Individual and simultaneous monoclonal antibody-based immunoassays of prostate-specific antigen and prostatic acid phosphatase. J Clin Immunoassay 1986;9:159-63.
10. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
11. Miki M, Machida T, Yanagisawa M, Yoshida M, Yamozaki H, Kondo N, et al. Clinical evaluation of serum prostatic specific antigen measurement by radioimmunoassay. Jpn J Urol 1984;75:1982-8.
12. Chan DW, Bruzek DJ, Oesterling JE, Rock RC, Walsh PC. Prostate-specific antigen as a marker for prostatic cancer a monoclonal and a polyclonal immunoassay compared. Clin Chem 1987;33:1916-20.
13. Ooi DS, Pronovost C, Escares E. Performance evaluation of DPC's IRMA Count PSA assay [Abstract]. Clin Chem 1990;36:1050.
14. Chybowski FM, Larson-Keller JJ, Bergstralh EJ, Oesterling JE. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate-specific antigen is superior to all other clinical parameters. J Urol 1991;145:313-8.
15. Giuliani L, Pescatore D, Giberti C, Martorana G, Natt G. Treatment of advanced prostatic carcinoma with cyproterone acetate and orchiectomy: 5-year follow-up. Eur Urol 1980;6:145-8.
16. Jacobsen SJ, Bergstralh EJ, Guess HA, Katusic SK, Klee GG, Oesterling JE, et al. Predictive properties of serum-prostate-specific antigen testing in a community-based setting Arch Intern Med 1996;156:2462-8.
17. Meigs JB, Barry MJ, Oesterling JE, Jacobsen SJ. Interpreting results of prostate-specific antigen testing for early detection of prostate cancer J Gen Intern Med 1996;11:505-12.
18. Brewer MK. Laboratory studies for the detection of carcinoma of the prostate. Urol Clin North Am 1990;17:759-68.
19. Bernstein LH, Rudolph RA, Pinto MM, Viner N, Zuckerman H. Medically significant concentrations of prostate-specific antigen in blood assessed. Clin Chem 1990;36:515-8.
20. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL. Prostatic specific antigen and prostatic acid phosphatase and staging of patients with prostatic cancer. J Urol 1987;138:1181-4.
21. Armitage TG, Cooper EH, Newling DW, Robinson MR, Appleyard I. The value of the measurement of serum prostate-specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer. Br J Urol 1988;62:584-9.
22. Palken M, Cobb DE, Warren BH, Hoak DC. Prostate cancer correlation of digital rectal examination, trans rectal ultrasound and prostate specific antigen levels with tumor volume in radical prostatectomy specimens. J Urol 1990;143:1155-62.
23. Dijkman GA, Debruyne FM. Epidemiology of prostate cancer. Eur Urol 1996;30:281-95.
24. Leitenberger A, Altwein JE. Efficacy and discriminative ability of prostate-specific antigen as a tumor marker. Eur Urol 1990;17:12-16.